chr8-27464080-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000742.4(CHRNA2):​c.450-87C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.844 in 1,517,462 control chromosomes in the GnomAD database, including 543,356 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 51568 hom., cov: 31)
Exomes 𝑓: 0.85 ( 491788 hom. )

Consequence

CHRNA2
NM_000742.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.02

Publications

10 publications found
Variant links:
Genes affected
CHRNA2 (HGNC:1956): (cholinergic receptor nicotinic alpha 2 subunit) Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]
CHRNA2 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 4
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • benign familial infantile epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 8-27464080-G-C is Benign according to our data. Variant chr8-27464080-G-C is described in ClinVar as [Benign]. Clinvar id is 670757.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.853 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNA2NM_000742.4 linkc.450-87C>G intron_variant Intron 5 of 6 ENST00000407991.3 NP_000733.2 Q15822-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNA2ENST00000407991.3 linkc.450-87C>G intron_variant Intron 5 of 6 5 NM_000742.4 ENSP00000385026.1 Q15822-1

Frequencies

GnomAD3 genomes
AF:
0.821
AC:
124736
AN:
151988
Hom.:
51536
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.776
Gnomad AMI
AF:
0.877
Gnomad AMR
AF:
0.808
Gnomad ASJ
AF:
0.935
Gnomad EAS
AF:
0.555
Gnomad SAS
AF:
0.850
Gnomad FIN
AF:
0.836
Gnomad MID
AF:
0.937
Gnomad NFE
AF:
0.859
Gnomad OTH
AF:
0.846
GnomAD4 exome
AF:
0.847
AC:
1156463
AN:
1365356
Hom.:
491788
AF XY:
0.848
AC XY:
576511
AN XY:
679882
show subpopulations
African (AFR)
AF:
0.776
AC:
24173
AN:
31156
American (AMR)
AF:
0.809
AC:
31342
AN:
38762
Ashkenazi Jewish (ASJ)
AF:
0.925
AC:
23266
AN:
25158
East Asian (EAS)
AF:
0.573
AC:
21269
AN:
37118
South Asian (SAS)
AF:
0.868
AC:
70581
AN:
81322
European-Finnish (FIN)
AF:
0.836
AC:
42183
AN:
50462
Middle Eastern (MID)
AF:
0.924
AC:
3788
AN:
4098
European-Non Finnish (NFE)
AF:
0.857
AC:
891742
AN:
1040376
Other (OTH)
AF:
0.846
AC:
48119
AN:
56904
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
9298
18595
27893
37190
46488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19522
39044
58566
78088
97610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.821
AC:
124820
AN:
152106
Hom.:
51568
Cov.:
31
AF XY:
0.818
AC XY:
60823
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.775
AC:
32157
AN:
41470
American (AMR)
AF:
0.808
AC:
12345
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.935
AC:
3248
AN:
3472
East Asian (EAS)
AF:
0.554
AC:
2857
AN:
5154
South Asian (SAS)
AF:
0.849
AC:
4096
AN:
4826
European-Finnish (FIN)
AF:
0.836
AC:
8858
AN:
10602
Middle Eastern (MID)
AF:
0.932
AC:
274
AN:
294
European-Non Finnish (NFE)
AF:
0.859
AC:
58401
AN:
67990
Other (OTH)
AF:
0.847
AC:
1784
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1099
2198
3297
4396
5495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.811
Hom.:
2556
Bravo
AF:
0.817
Asia WGS
AF:
0.716
AC:
2490
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 54% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 50. Only high quality variants are reported. -

Autosomal dominant nocturnal frontal lobe epilepsy 4 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.81
DANN
Benign
0.56
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3735757; hg19: chr8-27321597; COSMIC: COSV53560442; COSMIC: COSV53560442; API